Diagnosis and management of community and hospital acquired pneumonia in adults: Summary of NICE guidance

The BMJ

Volumn 349, Issue , 2014, Pages

  Eccles, Sinan ^a   Pincus, Celia ^b   Higgins, Bernard ^b,c   Woodhead, Mark ^d   Aliyu, Sani ^e   Ashton, Corinne ^e   Brown, Jeremy ^e   Greenwood, Sonia ^e   Jaafar, Ahmed F ^e   Lim, Wei Shen ^e   Moore, Michael ^e   Orme, Susie ^e   Roper, Lesley Ann ^e   Searle, Steve ^e   Watkins, John ^e   Hooper, James ^e   Daniels, Ron ^e  

^a ROYAL GWENT HOSPITAL   (United Kingdom)

^b ROYAL COLLEGE OF PHYSICIANS   (United Kingdom)

^c FREEMAN HOSPITAL   (United Kingdom)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CEFTAROLINE FOSAMIL; CEFTRIAXONE; CEFUROXIME; GLUCOCORTICOID; MACROLIDE; PIPERACILLIN PLUS TAZOBACTAM; TETRACYCLINE; ANTIINFECTIVE AGENT; C REACTIVE PROTEIN; CORTICOSTEROID;

ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ASSESSMENT; CLINICAL PRACTICE; COMMUNITY ACQUIRED PNEUMONIA; DISEASE SEVERITY; EARLY INTERVENTION; HOSPITAL ACQUIRED PNEUMONIA; HOSPITAL DISCHARGE; HUMAN; LOWER RESPIRATORY TRACT INFECTION; NATIONAL HEALTH ORGANIZATION; PATIENT INFORMATION; PATIENT MONITORING; PRACTICE GUIDELINE; STEROID THERAPY; UNCERTAINTY; VENTILATOR ASSOCIATED PNEUMONIA; ADULT; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; HOSPITALIZATION; PNEUMONIA; UNITED KINGDOM;

ADRENAL CORTEX HORMONES; ADULT; ANTI-BACTERIAL AGENTS; C-REACTIVE PROTEIN; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; GREAT BRITAIN; HOSPITALIZATION; HUMANS; PNEUMONIA; PRACTICE GUIDELINES AS TOPIC;

EID: 84917674471     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g6722     Document Type: Article

References (11)

1. Lim WS, Rodrigo C. British Thoracic Society adult community acquired pneumonia audit 2012/13. 2013. www.brit-thoracic.org.uk/document-library/audit-and-quality-improvement/audit-reports/bts-adult-community-acquired-pneumonia-audit-report-201213/.
2. Macfarlane JT, Colville A, Guion A, Macfarlane RM, Rose DH. Prospective study of aetiology and outcome of adult lower-respiratory-tract infections in the community. Lancet 1993;341:511-4.
3. Woodhead MA, Macfarlane JT, McCracken JS, Rose DH, Finch RG. Prospective study of the aetiology and outcome of pneumonia in the community. Lancet 1987;1:671-4.
4. Guest JF, Morris A. Community-acquired pneumonia: the annual cost to the National Health Service in the UK. Eur Respir J 1997;10:1530-4.
5. Lim WS, Woodhead M. British Thoracic Society adult community acquired pneumonia audit 2009/10. Thorax 2011;66:548-9.
6. Meehan TP, Weingarten SR, Holmboe ES, Mathur D, Wang Y, Petrillo MK, et al. A statewide initiative to improve the care of hospitalized pneumonia patients: the Connecticut Pneumonia Pathway Project. Am J Med 2001;111:203-10.
7. McCabe C, Kirchner C, Zhang H, Daley J, Fisman DN. Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules. Arch Intern Med 2009;169:1525-31.
8. Leu HS, Kaiser DL, Mori M, Woolson RF, Wenzel RP. Hospital-acquired pneumonia: attributable mortality and morbidity. Am J Epidemiol 1989;129:1258-67.
9. Masterton RG, Galloway A, French G, Street M, Armstrong J, Brown E, et al. Guidelines for the management of hospital-acquired pneumonia in the UK: report of the Working Party on Hospital-Acquired Pneumonia of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 2008;62:5-34.
10. National Institute for Health and Care Excellence. Pneumonia (including community acquired pneumonia). 2014. www.nice.org.uk/guidance/cg191.
11. Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, et al. Defining community-acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003;58:377-82